This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Abbott Laboratories (ABT)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 3.48B 10.80B 6.81B 3.65B
Receivables 3.99B 7.61B 7.68B 7.18B
Inventories 2.69B 3.79B 3.28B 3.19B
Other Current Assets 438.00M 0.00 0.00 1.87B
Total Current Assets 19.25B 31.32B 23.77B 22.32B
Property, Plant & Equipment, Gross 12.87B 18.93B 18.02B 17.37B
Accumulated Depreciation & Depletion 6.96B 10.87B 10.14B 9.40B
Property, Plant & Equipment, Net 5.90B 8.06B 7.87B 7.97B
Intangibles 5.74B 8.59B 9.99B 12.15B
Other Non-Current Assets 185.00M 273.60M 378.22M 302.05M
Total Non-Current Assets 23.71B 35.91B 36.51B 37.14B
Liabilities & Shareholder Equity
Total Assets 42.95B 67.23B 60.28B 59.46B
Accounts Payable 1.03B 1.80B 1.72B 1.54B
Short Term Debt 3.17B 2.39B 3.37B 6.39B
Other Current Liabilities 902.00M 876.76M 1.27B 1.99B
Total Current Liabilities 9.51B 13.28B 15.48B 17.26B
Long Term Debt 3.39B 18.09B 12.04B 12.52B
Deferred Income Taxes 466.00M 0.00 0.00 0.00
Other Non-Current Liabilities 4.32B 9.06B 8.23B 7.20B
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 8.28B 27.23B 20.36B 19.81B
Total Liabilities 17.78B 40.51B 35.84B 37.07B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 25.17B 26.72B 24.44B 22.39B
Common Par 0.00 11.75B 0.00 0.00
Additional Paid In Capital 12.05B 0.00 9.82B 8.74B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 21.98B 24.15B 20.91B 18.93B
Treasury Stock -6.84B -5.59B -3.69B -3.92B
Other Equity Adjustments -2.01B -3.59B -2.60B -1.37B
Total Capitalization 28.56B 44.81B 36.48B 34.91B
Total Equity 25.17B 26.72B 24.44B 22.39B
Total Liabilities & Stock Equity 42.95B 67.23B 60.28B 59.46B
Total Common Shares Outstanding 1.55B 1.58B 1.57B 1.55B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 137.73M 99.26M 68.49M 72.71M
Basic Weighted Shares Outstanding 1.56B 1.58B 1.56B 1.55B
Diluted Weighted Shares Outstanding 1.57B 1.59B 1.57B 1.56B
Number of Employees 69000 91000 91000 90000
Number of Part-Time Employees 0 0 0 0
ABT News

ABT Abbott Laboratories

Analysts Ratings for ABT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 7 7 7
Moderate Buy 4 4 4 3
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ABT ANALYST REPORT

Brokerage Partners

ABT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs